Review



cb101 bl21 de3 competent cells tiangen  (tiangen biotech co)


Bioz Verified Symbol tiangen biotech co is a verified supplier
Bioz Manufacturer Symbol tiangen biotech co manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    tiangen biotech co cb101 bl21 de3 competent cells tiangen
    Cb101 Bl21 De3 Competent Cells Tiangen, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 99/100, based on 13 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)/pm32640214-252-198-203
    Average 99 stars, based on 13 article reviews
    cb101 bl21 de3 competent cells tiangen - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Virus:

    Article Title: ATG5 attenuates inflammatory signaling in mouse embryonic stem cells to control differentiation.
    Article Snippet: Article ATG5 attenuates inflammatory signaling in mouse embryonic stem cells to control differentiation

    Article Title: Gut microbial DL-endopeptidase alleviates Crohn's disease via the NOD2 pathway.
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies E-cadherin Abcam Cat# ab231303; RRID: AB_562059 Rabbit polyclonal anti-UC118 This paper N/A Rabbit polyclonal anti-PCNA Proteintech Cat# 10205-2-AP; RRID: AB_2160330 Rabbit polyclonal anti-Cleaved-caspase 3 Cell Signaling Technology Cat# 9661; RRID: AB_2341188 Bacterial and virus strains BL21 (DE3) chemically competent E. coli TIANGEN Cat# CB105-01 Bacillus cereus Lab stock N/A Bacillus licheniformis Lab stock N/A Bacillus subtilis Lab stock N/A Bacillus thermoamylovorans Lab stock N/A Bacteroides caccae Lab stock N/A Bacteroides cellulosilyticus Lab stock N/A Bacteroides dorei Lab stock N/A Bacteroides eggerthii Lab stock N/A Bacteroides fragilis Lab stock N/A Bacteroides ovatus Lab stock N/A Bacteroides plebeius Lab stock N/A Bacteroides stercoris Lab stock N/A Bacteroides vulgatus 1 Lab stock N/A Bacteroides vulgatus Lab stock N/A Blautia obeum strain Lab stock N/A Clostridium butyricum Lab stock N/A Enterococcus avium Lab stock N/A Enterococcus casseliflavus Lab stock N/A Enterococcus faecalis Lab stock N/A Enterococcus faecium 1 Lab stock N/A Enterococcus faecium 2 Lab stock N/A Enterococcus hirae Lab stock N/A Escherichia coli ATCC Cat# ATCC 25922 Lactobacillus acidophilus Lab stock N/A Lactobacillus delbrueckii Lab stock N/A Lactobacillus gasseri Lab stock N/A Lactobacillus oris Lab stock N/A Lactobacillus paracasei Lab stock N/A Lactobacillus plantarum Lab stock N/A Lactobacillus rhamnosus Lab stock N/A Lactobacillus salivarius Lab stock N/A Lactobacillus vaginalis Lab stock N/A Parabacteroides distasonis Lab stock N/A Parabacteroides gordonii Lab stock N/A Parabacteroides merdae Lab stock N/A Ruminococcus gnavus Lab stock N/A Staphylococcus aureus 1 ATCC Cat# ATCC 25923 Staphylococcus aureus 2 Lab stock N/A Streptococcus anginosus Lab stock N/A (Continued on next page) e1 Cell Host & Microbe 30, 1435–1449.e1–e9, October 12, 2022 .. REAGENT or RESOURCE SOURCE IDENTIFIER Streptococcus cristatus Lab stock N/A Streptococcus gallolyticus Lab stock N/A Streptococcus gordonii Lab stock N/A Streptococcus mitis Lab stock N/A Streptococcus parasanguinis Lab stock N/A Streptococcus pasteurianus Lab stock N/A Streptococcus salivarius Lab stock N/A Biological samples Fecal samples Zhujiang Hospital N/A Blood samples Zhujiang Hospital N/A Chemicals, peptides, and recombinant proteins 2,4,6-trinitrobenzenesulfonic acid Sigma-Aldrich Cat# P2297; CAS:2508-19-2 Dextran sodium sulfate Aladdin Cat# D12235; CAS: 9011-18-1 FITC-dextran Sigma-Aldrich Cat# FD40S; CAS: 60842-46-8 Bovine serum albumin Sigma-Aldrich Cat# V900933; CAS: 9048-46-8 Difco Skim Milk BD biosciences Cat# BD-232100 Polyvinylidene difluoride membrane Sigma-Aldrich Cat# 3010040001 Blocking goat serum Solarbio Cat# SL038 Citrate buffer solution,pH 6.0,103 Sigma-Aldrich Cat# C9999 MDP Sigma-Aldrich Cat# A9519; CAS: 53678-77-6 GSK717 Med Chem Express Cat# HY-136555 Dulbecco eagle medium, high glucose GIBCO Cat# 11965092 Heat inactivated fetal bovine serum (FBS) GIBCO Cat# 10100147 Brain Heart Infusion Huankai Microbial Cat# 028361 PYG Broth Huankai Microbial Cat# 027340 Kanamycin sulfate Sigma-Aldrich Cat# 420311; CAS: 25389-94-0 DAPI Sigma-Aldrich Cat# D9542; CAS: 28718-90-3 Isopropyl-b-d-thiogalactoside Sigma-Aldrich Cat# I6758; CAS: 367-93-1 Peptidoglycan from S. aureus Sigma-Aldrich Cat# 77140 Muramidase Sigma-Aldrich Cat# L4919 EcoRI Takara Cat# 1040A XhoI Takara Cat# 1094A Sac I Takara Cat# 1078A BamH I Takara Cat# 1010A DMSO Sigma-Aldrich Cat# D2650; CAS: 67-68-5 Glycerin Solarbio G8190 Mutanolysin Sigma-Aldrich Cat# M9901; CAS: 55466-22-3 Syrings Filters (0.22 mm) NEST Cat# 331011 L-Glutamine Solution Sigma-Aldrich Cat# 59202C; CAS: 56-85-9 Normocin InvivoGen Cat# ant-nr-1 Blasticidin InvivoGen Cat# ant-bl-05 Zeocin InvivoGen Cat# ant-zn-05 Pectin Aladdin Cat# P112756 HEK-Blue Detection InvivoGen Cat# hb-det2 Zein Aladdin Cat# Z304904; CAS: 9010-66-6 Calcium chloride Sigma-Aldrich Cat# 499609; CAS: 10043-52-4 Hematoxylin-Eosin Solarbio Cat# G1120 5-kDa MWCO columns Sigma-Aldrich Cat# CLS431477 Hypersil GOLD C18 column Thermo Scientific Cat# 25005-059070A (Continued on next page) Cell Host & Microbe 30, 1435–1449.e1–e9, October 12, 2022 e2

    shRNA:

    Article Title: ATG5 attenuates inflammatory signaling in mouse embryonic stem cells to control differentiation.
    Article Snippet: Article ATG5 attenuates inflammatory signaling in mouse embryonic stem cells to control differentiation

    Recombinant:

    Article Title: ATG5 attenuates inflammatory signaling in mouse embryonic stem cells to control differentiation.
    Article Snippet: Article ATG5 attenuates inflammatory signaling in mouse embryonic stem cells to control differentiation

    Article Title: Cell-type-specific defense priming and NHP-dependent systemic immunity against Pectobacterium in Chinese cabbage
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples atwrky18 AraShare SALK_093916C atwrky33 Prof. Yiming Wang Lab GABI_324B11 atald1 AraShare SALK_061866C atsard4 AraShare SALK_131295C atfmo1 AraShare SALK_026163 atpr4 AraShare SALK_082089C atpr3 AraShare SALK_043790C OE-BrWRKY33-1 in atwrky18 This paper N/A pBrWRKY18-1::NLS-eGFP in Arabidopsis This paper N/A pBrWRKY33-1::NLS-eGFP in Arabidopsis This paper N/A Chinese cabbage variety A03 This paper N/A Nicotiana benthamiana This paper N/A Pectobacterium carotovorum BC1 (Pc BC1) This paper N/A Escherichia coli BL21 (DE3) TIANGEN CatCB105-01 Escherichia coli DH5a TIANGEN Cat#CB101 Agrobacterium tumefaciens strain GV3101 WEIDI Cat#AC1001 Yeast strain Y1HGold PYEAST Cat#PG1028 Chemicals, peptides, and recombinant proteins Dithiothreitol Sigma Cat#D9779 Protease Inhibitor Cocktail for Plants Sigma Cat#P9599 DAPI Solarbio Cat#C0060 ReverTra Ace qPCR RT Master Mix TOYOBO Cat#A1172K THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#A4251K Aureobasidin A Coolaber Cat#CA2332G KOD-Plus-Neo TOYOBO Cat#KOD-401 Critical commercial assays CelLytic TM PN Isolation/Extraction Kit Sigma Cat#CELLYTPN1 GUS stain Kit Coolaber Cat#SL7160 RNA extraction kit Promega Cat# LS1040 In-Fusion® HD Cloning Kit Takara Cat#639649 Chemiluminescent EMSA Kit Beyotime Cat#GS009 TIANprep Mini Plasmid Kit TIANGEN Cat#DP103 HighPure Maxi Plasmid Kit TIANGEN Cat#DP116 Deposited data Single-nucleus RNA-seq data This paper SRA: PRJNA1282792 Recombinant DNA pTY-BrPDS This paper N/A pTY-BrWRKY18-1 This paper N/A pTY-BrWRKY33-1 This paper N/A pTY-BrPR3 This paper N/A pTY-BrPR4-1 This paper N/A pTY-BrPR4-2 This paper N/A (Continued on next page) Cell Reports 44, 116479, November 25, 2025 19 ..

    CCK-8 Assay:

    Article Title: ATG5 attenuates inflammatory signaling in mouse embryonic stem cells to control differentiation.
    Article Snippet: Article ATG5 attenuates inflammatory signaling in mouse embryonic stem cells to control differentiation

    Transformation Assay:

    Article Title: 4-Oxo-2-Nonenal- and Agitation-Induced Aggregates of α-Synuclein and Phosphorylated α-Synuclein with Distinct Biophysical Properties and Biomedical Applications
    Article Snippet: .. Briefly, competent BL21 (DE3) cells (CB105-01; Tiangen Biotech Co., Ltd., Beijing, China) were transformed with the pGEX-4T-1 expression vector coding for full-length human α-syn. ..

    Article Title: Serine-129 Phosphorylated α-Synuclein Regulates Endoplasmic Reticulum-Mitochondria Calcium Homeostasis via Interaction with VAPB and PTPIP51 in an α-Synuclein-induced Parkinson Disease Model
    Article Snippet: .. Human full-length α-syn cDNA was cloned into the pGEX-4T-1 vector and transformed into BL21 (DE3) Escherichia coli (CB105-01; Tiangen, Beijing, China). ..

    Expressing:

    Article Title: 4-Oxo-2-Nonenal- and Agitation-Induced Aggregates of α-Synuclein and Phosphorylated α-Synuclein with Distinct Biophysical Properties and Biomedical Applications
    Article Snippet: .. Briefly, competent BL21 (DE3) cells (CB105-01; Tiangen Biotech Co., Ltd., Beijing, China) were transformed with the pGEX-4T-1 expression vector coding for full-length human α-syn. ..

    Clone Assay:

    Article Title: Serine-129 Phosphorylated α-Synuclein Regulates Endoplasmic Reticulum-Mitochondria Calcium Homeostasis via Interaction with VAPB and PTPIP51 in an α-Synuclein-induced Parkinson Disease Model
    Article Snippet: .. Human full-length α-syn cDNA was cloned into the pGEX-4T-1 vector and transformed into BL21 (DE3) Escherichia coli (CB105-01; Tiangen, Beijing, China). ..

    Protease Inhibitor:

    Article Title: Cell-type-specific defense priming and NHP-dependent systemic immunity against Pectobacterium in Chinese cabbage
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples atwrky18 AraShare SALK_093916C atwrky33 Prof. Yiming Wang Lab GABI_324B11 atald1 AraShare SALK_061866C atsard4 AraShare SALK_131295C atfmo1 AraShare SALK_026163 atpr4 AraShare SALK_082089C atpr3 AraShare SALK_043790C OE-BrWRKY33-1 in atwrky18 This paper N/A pBrWRKY18-1::NLS-eGFP in Arabidopsis This paper N/A pBrWRKY33-1::NLS-eGFP in Arabidopsis This paper N/A Chinese cabbage variety A03 This paper N/A Nicotiana benthamiana This paper N/A Pectobacterium carotovorum BC1 (Pc BC1) This paper N/A Escherichia coli BL21 (DE3) TIANGEN CatCB105-01 Escherichia coli DH5a TIANGEN Cat#CB101 Agrobacterium tumefaciens strain GV3101 WEIDI Cat#AC1001 Yeast strain Y1HGold PYEAST Cat#PG1028 Chemicals, peptides, and recombinant proteins Dithiothreitol Sigma Cat#D9779 Protease Inhibitor Cocktail for Plants Sigma Cat#P9599 DAPI Solarbio Cat#C0060 ReverTra Ace qPCR RT Master Mix TOYOBO Cat#A1172K THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#A4251K Aureobasidin A Coolaber Cat#CA2332G KOD-Plus-Neo TOYOBO Cat#KOD-401 Critical commercial assays CelLytic TM PN Isolation/Extraction Kit Sigma Cat#CELLYTPN1 GUS stain Kit Coolaber Cat#SL7160 RNA extraction kit Promega Cat# LS1040 In-Fusion® HD Cloning Kit Takara Cat#639649 Chemiluminescent EMSA Kit Beyotime Cat#GS009 TIANprep Mini Plasmid Kit TIANGEN Cat#DP103 HighPure Maxi Plasmid Kit TIANGEN Cat#DP116 Deposited data Single-nucleus RNA-seq data This paper SRA: PRJNA1282792 Recombinant DNA pTY-BrPDS This paper N/A pTY-BrWRKY18-1 This paper N/A pTY-BrWRKY33-1 This paper N/A pTY-BrPR3 This paper N/A pTY-BrPR4-1 This paper N/A pTY-BrPR4-2 This paper N/A (Continued on next page) Cell Reports 44, 116479, November 25, 2025 19 ..

    Real-time Polymerase Chain Reaction:

    Article Title: Cell-type-specific defense priming and NHP-dependent systemic immunity against Pectobacterium in Chinese cabbage
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples atwrky18 AraShare SALK_093916C atwrky33 Prof. Yiming Wang Lab GABI_324B11 atald1 AraShare SALK_061866C atsard4 AraShare SALK_131295C atfmo1 AraShare SALK_026163 atpr4 AraShare SALK_082089C atpr3 AraShare SALK_043790C OE-BrWRKY33-1 in atwrky18 This paper N/A pBrWRKY18-1::NLS-eGFP in Arabidopsis This paper N/A pBrWRKY33-1::NLS-eGFP in Arabidopsis This paper N/A Chinese cabbage variety A03 This paper N/A Nicotiana benthamiana This paper N/A Pectobacterium carotovorum BC1 (Pc BC1) This paper N/A Escherichia coli BL21 (DE3) TIANGEN CatCB105-01 Escherichia coli DH5a TIANGEN Cat#CB101 Agrobacterium tumefaciens strain GV3101 WEIDI Cat#AC1001 Yeast strain Y1HGold PYEAST Cat#PG1028 Chemicals, peptides, and recombinant proteins Dithiothreitol Sigma Cat#D9779 Protease Inhibitor Cocktail for Plants Sigma Cat#P9599 DAPI Solarbio Cat#C0060 ReverTra Ace qPCR RT Master Mix TOYOBO Cat#A1172K THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#A4251K Aureobasidin A Coolaber Cat#CA2332G KOD-Plus-Neo TOYOBO Cat#KOD-401 Critical commercial assays CelLytic TM PN Isolation/Extraction Kit Sigma Cat#CELLYTPN1 GUS stain Kit Coolaber Cat#SL7160 RNA extraction kit Promega Cat# LS1040 In-Fusion® HD Cloning Kit Takara Cat#639649 Chemiluminescent EMSA Kit Beyotime Cat#GS009 TIANprep Mini Plasmid Kit TIANGEN Cat#DP103 HighPure Maxi Plasmid Kit TIANGEN Cat#DP116 Deposited data Single-nucleus RNA-seq data This paper SRA: PRJNA1282792 Recombinant DNA pTY-BrPDS This paper N/A pTY-BrWRKY18-1 This paper N/A pTY-BrWRKY33-1 This paper N/A pTY-BrPR3 This paper N/A pTY-BrPR4-1 This paper N/A pTY-BrPR4-2 This paper N/A (Continued on next page) Cell Reports 44, 116479, November 25, 2025 19 ..

    Isolation:

    Article Title: Cell-type-specific defense priming and NHP-dependent systemic immunity against Pectobacterium in Chinese cabbage
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples atwrky18 AraShare SALK_093916C atwrky33 Prof. Yiming Wang Lab GABI_324B11 atald1 AraShare SALK_061866C atsard4 AraShare SALK_131295C atfmo1 AraShare SALK_026163 atpr4 AraShare SALK_082089C atpr3 AraShare SALK_043790C OE-BrWRKY33-1 in atwrky18 This paper N/A pBrWRKY18-1::NLS-eGFP in Arabidopsis This paper N/A pBrWRKY33-1::NLS-eGFP in Arabidopsis This paper N/A Chinese cabbage variety A03 This paper N/A Nicotiana benthamiana This paper N/A Pectobacterium carotovorum BC1 (Pc BC1) This paper N/A Escherichia coli BL21 (DE3) TIANGEN CatCB105-01 Escherichia coli DH5a TIANGEN Cat#CB101 Agrobacterium tumefaciens strain GV3101 WEIDI Cat#AC1001 Yeast strain Y1HGold PYEAST Cat#PG1028 Chemicals, peptides, and recombinant proteins Dithiothreitol Sigma Cat#D9779 Protease Inhibitor Cocktail for Plants Sigma Cat#P9599 DAPI Solarbio Cat#C0060 ReverTra Ace qPCR RT Master Mix TOYOBO Cat#A1172K THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#A4251K Aureobasidin A Coolaber Cat#CA2332G KOD-Plus-Neo TOYOBO Cat#KOD-401 Critical commercial assays CelLytic TM PN Isolation/Extraction Kit Sigma Cat#CELLYTPN1 GUS stain Kit Coolaber Cat#SL7160 RNA extraction kit Promega Cat# LS1040 In-Fusion® HD Cloning Kit Takara Cat#639649 Chemiluminescent EMSA Kit Beyotime Cat#GS009 TIANprep Mini Plasmid Kit TIANGEN Cat#DP103 HighPure Maxi Plasmid Kit TIANGEN Cat#DP116 Deposited data Single-nucleus RNA-seq data This paper SRA: PRJNA1282792 Recombinant DNA pTY-BrPDS This paper N/A pTY-BrWRKY18-1 This paper N/A pTY-BrWRKY33-1 This paper N/A pTY-BrPR3 This paper N/A pTY-BrPR4-1 This paper N/A pTY-BrPR4-2 This paper N/A (Continued on next page) Cell Reports 44, 116479, November 25, 2025 19 ..

    Staining:

    Article Title: Cell-type-specific defense priming and NHP-dependent systemic immunity against Pectobacterium in Chinese cabbage
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples atwrky18 AraShare SALK_093916C atwrky33 Prof. Yiming Wang Lab GABI_324B11 atald1 AraShare SALK_061866C atsard4 AraShare SALK_131295C atfmo1 AraShare SALK_026163 atpr4 AraShare SALK_082089C atpr3 AraShare SALK_043790C OE-BrWRKY33-1 in atwrky18 This paper N/A pBrWRKY18-1::NLS-eGFP in Arabidopsis This paper N/A pBrWRKY33-1::NLS-eGFP in Arabidopsis This paper N/A Chinese cabbage variety A03 This paper N/A Nicotiana benthamiana This paper N/A Pectobacterium carotovorum BC1 (Pc BC1) This paper N/A Escherichia coli BL21 (DE3) TIANGEN CatCB105-01 Escherichia coli DH5a TIANGEN Cat#CB101 Agrobacterium tumefaciens strain GV3101 WEIDI Cat#AC1001 Yeast strain Y1HGold PYEAST Cat#PG1028 Chemicals, peptides, and recombinant proteins Dithiothreitol Sigma Cat#D9779 Protease Inhibitor Cocktail for Plants Sigma Cat#P9599 DAPI Solarbio Cat#C0060 ReverTra Ace qPCR RT Master Mix TOYOBO Cat#A1172K THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#A4251K Aureobasidin A Coolaber Cat#CA2332G KOD-Plus-Neo TOYOBO Cat#KOD-401 Critical commercial assays CelLytic TM PN Isolation/Extraction Kit Sigma Cat#CELLYTPN1 GUS stain Kit Coolaber Cat#SL7160 RNA extraction kit Promega Cat# LS1040 In-Fusion® HD Cloning Kit Takara Cat#639649 Chemiluminescent EMSA Kit Beyotime Cat#GS009 TIANprep Mini Plasmid Kit TIANGEN Cat#DP103 HighPure Maxi Plasmid Kit TIANGEN Cat#DP116 Deposited data Single-nucleus RNA-seq data This paper SRA: PRJNA1282792 Recombinant DNA pTY-BrPDS This paper N/A pTY-BrWRKY18-1 This paper N/A pTY-BrWRKY33-1 This paper N/A pTY-BrPR3 This paper N/A pTY-BrPR4-1 This paper N/A pTY-BrPR4-2 This paper N/A (Continued on next page) Cell Reports 44, 116479, November 25, 2025 19 ..

    RNA Extraction:

    Article Title: Cell-type-specific defense priming and NHP-dependent systemic immunity against Pectobacterium in Chinese cabbage
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples atwrky18 AraShare SALK_093916C atwrky33 Prof. Yiming Wang Lab GABI_324B11 atald1 AraShare SALK_061866C atsard4 AraShare SALK_131295C atfmo1 AraShare SALK_026163 atpr4 AraShare SALK_082089C atpr3 AraShare SALK_043790C OE-BrWRKY33-1 in atwrky18 This paper N/A pBrWRKY18-1::NLS-eGFP in Arabidopsis This paper N/A pBrWRKY33-1::NLS-eGFP in Arabidopsis This paper N/A Chinese cabbage variety A03 This paper N/A Nicotiana benthamiana This paper N/A Pectobacterium carotovorum BC1 (Pc BC1) This paper N/A Escherichia coli BL21 (DE3) TIANGEN CatCB105-01 Escherichia coli DH5a TIANGEN Cat#CB101 Agrobacterium tumefaciens strain GV3101 WEIDI Cat#AC1001 Yeast strain Y1HGold PYEAST Cat#PG1028 Chemicals, peptides, and recombinant proteins Dithiothreitol Sigma Cat#D9779 Protease Inhibitor Cocktail for Plants Sigma Cat#P9599 DAPI Solarbio Cat#C0060 ReverTra Ace qPCR RT Master Mix TOYOBO Cat#A1172K THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#A4251K Aureobasidin A Coolaber Cat#CA2332G KOD-Plus-Neo TOYOBO Cat#KOD-401 Critical commercial assays CelLytic TM PN Isolation/Extraction Kit Sigma Cat#CELLYTPN1 GUS stain Kit Coolaber Cat#SL7160 RNA extraction kit Promega Cat# LS1040 In-Fusion® HD Cloning Kit Takara Cat#639649 Chemiluminescent EMSA Kit Beyotime Cat#GS009 TIANprep Mini Plasmid Kit TIANGEN Cat#DP103 HighPure Maxi Plasmid Kit TIANGEN Cat#DP116 Deposited data Single-nucleus RNA-seq data This paper SRA: PRJNA1282792 Recombinant DNA pTY-BrPDS This paper N/A pTY-BrWRKY18-1 This paper N/A pTY-BrWRKY33-1 This paper N/A pTY-BrPR3 This paper N/A pTY-BrPR4-1 This paper N/A pTY-BrPR4-2 This paper N/A (Continued on next page) Cell Reports 44, 116479, November 25, 2025 19 ..

    Cloning:

    Article Title: Cell-type-specific defense priming and NHP-dependent systemic immunity against Pectobacterium in Chinese cabbage
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples atwrky18 AraShare SALK_093916C atwrky33 Prof. Yiming Wang Lab GABI_324B11 atald1 AraShare SALK_061866C atsard4 AraShare SALK_131295C atfmo1 AraShare SALK_026163 atpr4 AraShare SALK_082089C atpr3 AraShare SALK_043790C OE-BrWRKY33-1 in atwrky18 This paper N/A pBrWRKY18-1::NLS-eGFP in Arabidopsis This paper N/A pBrWRKY33-1::NLS-eGFP in Arabidopsis This paper N/A Chinese cabbage variety A03 This paper N/A Nicotiana benthamiana This paper N/A Pectobacterium carotovorum BC1 (Pc BC1) This paper N/A Escherichia coli BL21 (DE3) TIANGEN CatCB105-01 Escherichia coli DH5a TIANGEN Cat#CB101 Agrobacterium tumefaciens strain GV3101 WEIDI Cat#AC1001 Yeast strain Y1HGold PYEAST Cat#PG1028 Chemicals, peptides, and recombinant proteins Dithiothreitol Sigma Cat#D9779 Protease Inhibitor Cocktail for Plants Sigma Cat#P9599 DAPI Solarbio Cat#C0060 ReverTra Ace qPCR RT Master Mix TOYOBO Cat#A1172K THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#A4251K Aureobasidin A Coolaber Cat#CA2332G KOD-Plus-Neo TOYOBO Cat#KOD-401 Critical commercial assays CelLytic TM PN Isolation/Extraction Kit Sigma Cat#CELLYTPN1 GUS stain Kit Coolaber Cat#SL7160 RNA extraction kit Promega Cat# LS1040 In-Fusion® HD Cloning Kit Takara Cat#639649 Chemiluminescent EMSA Kit Beyotime Cat#GS009 TIANprep Mini Plasmid Kit TIANGEN Cat#DP103 HighPure Maxi Plasmid Kit TIANGEN Cat#DP116 Deposited data Single-nucleus RNA-seq data This paper SRA: PRJNA1282792 Recombinant DNA pTY-BrPDS This paper N/A pTY-BrWRKY18-1 This paper N/A pTY-BrWRKY33-1 This paper N/A pTY-BrPR3 This paper N/A pTY-BrPR4-1 This paper N/A pTY-BrPR4-2 This paper N/A (Continued on next page) Cell Reports 44, 116479, November 25, 2025 19 ..

    Plasmid Preparation:

    Article Title: Cell-type-specific defense priming and NHP-dependent systemic immunity against Pectobacterium in Chinese cabbage
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples atwrky18 AraShare SALK_093916C atwrky33 Prof. Yiming Wang Lab GABI_324B11 atald1 AraShare SALK_061866C atsard4 AraShare SALK_131295C atfmo1 AraShare SALK_026163 atpr4 AraShare SALK_082089C atpr3 AraShare SALK_043790C OE-BrWRKY33-1 in atwrky18 This paper N/A pBrWRKY18-1::NLS-eGFP in Arabidopsis This paper N/A pBrWRKY33-1::NLS-eGFP in Arabidopsis This paper N/A Chinese cabbage variety A03 This paper N/A Nicotiana benthamiana This paper N/A Pectobacterium carotovorum BC1 (Pc BC1) This paper N/A Escherichia coli BL21 (DE3) TIANGEN CatCB105-01 Escherichia coli DH5a TIANGEN Cat#CB101 Agrobacterium tumefaciens strain GV3101 WEIDI Cat#AC1001 Yeast strain Y1HGold PYEAST Cat#PG1028 Chemicals, peptides, and recombinant proteins Dithiothreitol Sigma Cat#D9779 Protease Inhibitor Cocktail for Plants Sigma Cat#P9599 DAPI Solarbio Cat#C0060 ReverTra Ace qPCR RT Master Mix TOYOBO Cat#A1172K THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#A4251K Aureobasidin A Coolaber Cat#CA2332G KOD-Plus-Neo TOYOBO Cat#KOD-401 Critical commercial assays CelLytic TM PN Isolation/Extraction Kit Sigma Cat#CELLYTPN1 GUS stain Kit Coolaber Cat#SL7160 RNA extraction kit Promega Cat# LS1040 In-Fusion® HD Cloning Kit Takara Cat#639649 Chemiluminescent EMSA Kit Beyotime Cat#GS009 TIANprep Mini Plasmid Kit TIANGEN Cat#DP103 HighPure Maxi Plasmid Kit TIANGEN Cat#DP116 Deposited data Single-nucleus RNA-seq data This paper SRA: PRJNA1282792 Recombinant DNA pTY-BrPDS This paper N/A pTY-BrWRKY18-1 This paper N/A pTY-BrWRKY33-1 This paper N/A pTY-BrPR3 This paper N/A pTY-BrPR4-1 This paper N/A pTY-BrPR4-2 This paper N/A (Continued on next page) Cell Reports 44, 116479, November 25, 2025 19 ..

    RNA Sequencing:

    Article Title: Cell-type-specific defense priming and NHP-dependent systemic immunity against Pectobacterium in Chinese cabbage
    Article Snippet: .. REAGENT or RESOURCE SOURCE IDENTIFIER Biological samples atwrky18 AraShare SALK_093916C atwrky33 Prof. Yiming Wang Lab GABI_324B11 atald1 AraShare SALK_061866C atsard4 AraShare SALK_131295C atfmo1 AraShare SALK_026163 atpr4 AraShare SALK_082089C atpr3 AraShare SALK_043790C OE-BrWRKY33-1 in atwrky18 This paper N/A pBrWRKY18-1::NLS-eGFP in Arabidopsis This paper N/A pBrWRKY33-1::NLS-eGFP in Arabidopsis This paper N/A Chinese cabbage variety A03 This paper N/A Nicotiana benthamiana This paper N/A Pectobacterium carotovorum BC1 (Pc BC1) This paper N/A Escherichia coli BL21 (DE3) TIANGEN CatCB105-01 Escherichia coli DH5a TIANGEN Cat#CB101 Agrobacterium tumefaciens strain GV3101 WEIDI Cat#AC1001 Yeast strain Y1HGold PYEAST Cat#PG1028 Chemicals, peptides, and recombinant proteins Dithiothreitol Sigma Cat#D9779 Protease Inhibitor Cocktail for Plants Sigma Cat#P9599 DAPI Solarbio Cat#C0060 ReverTra Ace qPCR RT Master Mix TOYOBO Cat#A1172K THUNDERBIRD SYBR qPCR Mix TOYOBO Cat#A4251K Aureobasidin A Coolaber Cat#CA2332G KOD-Plus-Neo TOYOBO Cat#KOD-401 Critical commercial assays CelLytic TM PN Isolation/Extraction Kit Sigma Cat#CELLYTPN1 GUS stain Kit Coolaber Cat#SL7160 RNA extraction kit Promega Cat# LS1040 In-Fusion® HD Cloning Kit Takara Cat#639649 Chemiluminescent EMSA Kit Beyotime Cat#GS009 TIANprep Mini Plasmid Kit TIANGEN Cat#DP103 HighPure Maxi Plasmid Kit TIANGEN Cat#DP116 Deposited data Single-nucleus RNA-seq data This paper SRA: PRJNA1282792 Recombinant DNA pTY-BrPDS This paper N/A pTY-BrWRKY18-1 This paper N/A pTY-BrWRKY33-1 This paper N/A pTY-BrPR3 This paper N/A pTY-BrPR4-1 This paper N/A pTY-BrPR4-2 This paper N/A (Continued on next page) Cell Reports 44, 116479, November 25, 2025 19 ..



    Similar Products

    96
    New England Biolabs competent e coli bl21 cells
    Competent E Coli Bl21 Cells, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21+Competent+E%2E+coli/bio_rxiv__64898__2026__11__03__764021-51-0-5
    Average 96 stars, based on 1 article reviews
    competent e coli bl21 cells - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Cytiva Europe e coli strain bl21
    E Coli Strain Bl21, supplied by Cytiva Europe, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/E%2E+coli+BL21/bio_rxiv__64898__2026__10__30__761943-252-15-24
    Average 96 stars, based on 1 article reviews
    e coli strain bl21 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    New England Biolabs e coli strain bl21 de3
    E Coli Strain Bl21 De3, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)+Competent+E%2E+coli/pm42790276-47-17-22
    Average 99 stars, based on 1 article reviews
    e coli strain bl21 de3 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    tiangen biotech co bl21 de3
    Bl21 De3, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)/pm42956452-44-5-9
    Average 99 stars, based on 1 article reviews
    bl21 de3 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    New England Biolabs bl21 de3
    Bl21 De3, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)+Competent+E%2E+coli/bio_rxiv__64898__2026__10__31__763323-150-15-17
    Average 99 stars, based on 1 article reviews
    bl21 de3 - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    93
    Addgene inc escherichia coli bl21 de3 codonplus cells
    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of <t>α-Syn</t> PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).
    Escherichia Coli Bl21 De3 Codonplus Cells, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/human+Alpha-synuclein+(Plasmid+%2351437)/bio_rxiv__64898__2026__11__02__763615-391-10-28
    Average 93 stars, based on 1 article reviews
    escherichia coli bl21 de3 codonplus cells - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    99
    New England Biolabs bl21 de3 cells
    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of <t>α-Syn</t> PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).
    Bl21 De3 Cells, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)+Competent+E%2E+coli/bio_rxiv__64898__2026__10__30__763152-263-4-7
    Average 99 stars, based on 1 article reviews
    bl21 de3 cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    96
    New England Biolabs bl21 competent escherichia coli cells
    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of <t>α-Syn</t> PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).
    Bl21 Competent Escherichia Coli Cells, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21+Competent+E%2E+coli/bio_rxiv__64898__2026__10__28__762535-296-9-14
    Average 96 stars, based on 1 article reviews
    bl21 competent escherichia coli cells - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    99
    tiangen biotech co e coli bl21 de3 cells
    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of <t>α-Syn</t> PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).
    E Coli Bl21 De3 Cells, supplied by tiangen biotech co, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bl21/BL21(DE3)/pm42965742-51-17-21
    Average 99 stars, based on 1 article reviews
    e coli bl21 de3 cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of α-Syn PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) Module scores of the Gene Ontology (GO) phagocytosis pathway in LPS-treated and untreated control microglia. (B) Representative immunofluorescence image (left panel) of primary microglia following 1 hr uptake of α-Syn PFFs (blue) and 70 kDa dextran (green), counterstained with LysoTracker Deep Red (red). Fluorescence intensity profiles (right panel) along the indicated line show overlap of all three signals. (C) Representative flow cytometry dot plot with marginal histograms showing 98.1% double-positive microglia for α-Syn PFFs and 70 kDa dextran. (D) Schematic overview of the α-Syn PFF uptake and degradation workflow for subsequent flow cytometry, immunofluorescence, and Western blot analyses. (E) Time-dependent uptake of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. n = 3, N = 6. (F) Time-dependent degradation of α-Syn PFFs by primary microglia exposed to increasing LPS concentrations (0-10 ng/ml), as quantified by flow cytometry. p<.0001 = ****. n = 3, N = 6. (G) Schematic overview of the experimental workflow to assess the effects of TLR4 inhibition with TAK-242 (500 nM) on α-Syn PFF clearance. (H) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs of the indicated treatments. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (I) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.05 = *, p<.01 = **. n=4. (J) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following 5 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowhead point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (K) Quantification of uptake and degradation of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. Kruskal-Wallis with Dunn’s post-hoc test and one-way ANOVA was calculated and compared by Tuckey’s post-hoc for all conditions p<.05 = *, p<.01 = **. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (E, F, H, I) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (J, K).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Control, Immunofluorescence, Fluorescence, Flow Cytometry, Western Blot, Inhibition, Staining, Synthesized

    (A) chematic overview of the experimental workflow to assess the effects of protein synthesis inhibition with cycloheximide (CHX, 50 µg/ml) on α-Syn PFF clearance. (B) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs treatment with CHX in the presence or absence of LPS. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (C) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.0001 = ****. n=4. (D) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following the indicated treatments and 3 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowheads point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (E) Quantification of α-Syn PFF uptake (left panel) and degradation (right panel) in primary microglia under the indicated treatment conditions. Degradation was expressed as a percentage of the uptake measurement. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple-comparisons test. p<.01 = **. n=3, N=6. (F) Schematic overview (left panel) of the experimental workflow to assess the effects of proteostatic stress induced by L-azetidine-2-carboxylic acid (AZC, 1 mM), a proline analogue that promotes protein misfolding and aggregation. Representative image (right panel) of protein aggregation using ProteoStat dye (red) and DAPI (blue). Scale bar: 20 µm. (G) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 h treatment with LPS or AZC. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). n=3, N=9 fields of view. p<.0001 = ****. Scale bar, 20 µm. (H) Quantification of uptake (right panel) and degradation (left panel) of α-Syn PFFs by primary microglia. Degradation is presented as percentage to uptake p<.001 = ***, p<.0001 = ****. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (B, E, G, H) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (D).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) chematic overview of the experimental workflow to assess the effects of protein synthesis inhibition with cycloheximide (CHX, 50 µg/ml) on α-Syn PFF clearance. (B) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 hrs treatment with CHX in the presence or absence of LPS. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). Ctrl and LPS conditions are identical to those shown in , as the data were obtained from the same experiment. n=3, N=9 fields of view. p<.0.001 = ***, p<.0001 = ****. Scale bar, 20 µm. (C) Representative Western blot (left panel) and quantification (right panel) showing newly synthesized proteins assessed by puromycin incorporation under the indicated treatment conditions. p<.0001 = ****. n=4. (D) Representative immunofluorescence images (left panel) and quantification of p62-positive aggregate size (right panel) in primary microglia following the indicated treatments and 3 hrs uptake of α-Syn PFFs (green). Cells were stained for p62 (red) and DAPI (blue). Arrowheads point to p62 aggregates. p<.0001 = ****. n = 3, N = 90-143 aggregates. Scale bar, 20 µm. (E) Quantification of α-Syn PFF uptake (left panel) and degradation (right panel) in primary microglia under the indicated treatment conditions. Degradation was expressed as a percentage of the uptake measurement. Statistical significance was determined using one-way ANOVA followed by Tukey’s multiple-comparisons test. p<.01 = **. n=3, N=6. (F) Schematic overview (left panel) of the experimental workflow to assess the effects of proteostatic stress induced by L-azetidine-2-carboxylic acid (AZC, 1 mM), a proline analogue that promotes protein misfolding and aggregation. Representative image (right panel) of protein aggregation using ProteoStat dye (red) and DAPI (blue). Scale bar: 20 µm. (G) Representative immunofluorescence images (left panel) and quantification of NF-κB nuclear enrichment (right panel) in primary microglia following 24 h treatment with LPS or AZC. Cells were stained for NF-κB (red), F-actin (green), and DAPI (blue). n=3, N=9 fields of view. p<.0001 = ****. Scale bar, 20 µm. (H) Quantification of uptake (right panel) and degradation (left panel) of α-Syn PFFs by primary microglia. Degradation is presented as percentage to uptake p<.001 = ***, p<.0001 = ****. n=3, N=9. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (B, E, G, H) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (D).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Inhibition, Immunofluorescence, Staining, Western Blot, Synthesized

    (A) Schematic overview of the canonical autophagy pathway and endolysosomal pathway. (B) Representative Western blot (left panel) and quantification (right panel) of autophagic flux assessed by LC3B-II accumulation in the presence or absence of bafilomycin A1 (BafA1, 100 nM, 4 hrs). LC3B-II protein levels were normalized to β-actin. n=7. (C) Representative Western blot (left panel) and quantification (right panel) of p62 protein levels in primary microglia following 24 hrs α-Syn PFF uptake and subsequent degradation for 24-72 h. p62 levels were normalized to β-actin. n=3. p<.05 = *. (D) Proteomics-derived module scores of the GO pathway “Late endosome to lysosome maturation” (upper panel) and “HOPS complex” (lower panel) under the indicated treatment conditions. p<.05 = *, p<.01 = **, p<.001 = ***, p<.0001 = ****. n=8. (E) Representative immunofluorescence images showing the subcellular localization of α-Syn PFFs (red), Rab7 (yellow), and cathepsin D (CatD, green) in primary microglia. Nuclei were counterstained with DAPI (blue). Three-dimensional reconstructions illustrate the spatial association of α-Syn PFFs with Rab7- and CatD-positive compartments, as indicated by arrowheads. Scale bar: 10 µm. (F) Representative immunofluorescence images (upper panel) of primary microglia following 24 hrs α-Syn PFF uptake (grey) in the presence or absence of LPS (10 ng/ml). Cells were stained for CatD (red) and F-actin (green). Fluorescence intensity profiles (lower panel) along the indicated lines show reduced colocalization of α-Syn PFFs with CatD-positive compartments following LPS treatment. Scale bars: 50 µm. (G) Quantification of α-Syn PFF puncta lacking CatD colocalization (free α-Syn puncta), expressed as absolute values and as a percentage of total α-Syn-positive area per cell. Measurements were performed following 24 hrs uptake (upper panel) and an additional 24 hrs degradation (lower panel) period under the indicated treatment conditions. p<.01 = **, p<.0001 = ****. n=3, N=104-199. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by t-test (G), one-way ANOVA followed by Tukey’s test (B, C) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (D).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) Schematic overview of the canonical autophagy pathway and endolysosomal pathway. (B) Representative Western blot (left panel) and quantification (right panel) of autophagic flux assessed by LC3B-II accumulation in the presence or absence of bafilomycin A1 (BafA1, 100 nM, 4 hrs). LC3B-II protein levels were normalized to β-actin. n=7. (C) Representative Western blot (left panel) and quantification (right panel) of p62 protein levels in primary microglia following 24 hrs α-Syn PFF uptake and subsequent degradation for 24-72 h. p62 levels were normalized to β-actin. n=3. p<.05 = *. (D) Proteomics-derived module scores of the GO pathway “Late endosome to lysosome maturation” (upper panel) and “HOPS complex” (lower panel) under the indicated treatment conditions. p<.05 = *, p<.01 = **, p<.001 = ***, p<.0001 = ****. n=8. (E) Representative immunofluorescence images showing the subcellular localization of α-Syn PFFs (red), Rab7 (yellow), and cathepsin D (CatD, green) in primary microglia. Nuclei were counterstained with DAPI (blue). Three-dimensional reconstructions illustrate the spatial association of α-Syn PFFs with Rab7- and CatD-positive compartments, as indicated by arrowheads. Scale bar: 10 µm. (F) Representative immunofluorescence images (upper panel) of primary microglia following 24 hrs α-Syn PFF uptake (grey) in the presence or absence of LPS (10 ng/ml). Cells were stained for CatD (red) and F-actin (green). Fluorescence intensity profiles (lower panel) along the indicated lines show reduced colocalization of α-Syn PFFs with CatD-positive compartments following LPS treatment. Scale bars: 50 µm. (G) Quantification of α-Syn PFF puncta lacking CatD colocalization (free α-Syn puncta), expressed as absolute values and as a percentage of total α-Syn-positive area per cell. Measurements were performed following 24 hrs uptake (upper panel) and an additional 24 hrs degradation (lower panel) period under the indicated treatment conditions. p<.01 = **, p<.0001 = ****. n=3, N=104-199. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by t-test (G), one-way ANOVA followed by Tukey’s test (B, C) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (D).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Western Blot, Proteomic Assay, Derivative Assay, Immunofluorescence, Staining, Fluorescence

    (A) Heatmap showing Z-score-normalized protein abundance of all proteins associated with the GO term “Lysosome” under the indicated treatment conditions. (B) Representative Western blot (left panel) and quantification (right panel) of CatD protein levels in primary microglia under the indicated treatment conditions. CatD levels were normalized to β-actin. Cropped regions of the Western blot are indicated by dashed lines. p<.05 = *, p<.01 = **. n=4. (C) Proteomics-derived TFEB protein abundance under the indicated treatment conditions, expressed as Z-scores. p<.01 = **. (D) Schematic overview of the experimental workflow to assess the effects of pharmacological TFEB activation on α-Syn PFF clearance. (E) Quantification of uptake (left panel) and degradation after 24 hrs (middle panel) and 48 hrs (right panel) of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. p<.01 = **, p<.0001 = ****. (F, G) Representative immunofluorescence images (right panel)) and quantification (left panel) of CatD-positive structures in primary microglia under the indicated treatment conditions. p<.01 = **, p<.001 = ***, p<.0001 = ****. n=3, N=34-118 (uptake) and N=17-125. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (B, E (uptake data)) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (C, E (degradation data), F, G).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) Heatmap showing Z-score-normalized protein abundance of all proteins associated with the GO term “Lysosome” under the indicated treatment conditions. (B) Representative Western blot (left panel) and quantification (right panel) of CatD protein levels in primary microglia under the indicated treatment conditions. CatD levels were normalized to β-actin. Cropped regions of the Western blot are indicated by dashed lines. p<.05 = *, p<.01 = **. n=4. (C) Proteomics-derived TFEB protein abundance under the indicated treatment conditions, expressed as Z-scores. p<.01 = **. (D) Schematic overview of the experimental workflow to assess the effects of pharmacological TFEB activation on α-Syn PFF clearance. (E) Quantification of uptake (left panel) and degradation after 24 hrs (middle panel) and 48 hrs (right panel) of α-Syn PFFs by microglia. Degradation is presented as percentage to uptake. p<.01 = **, p<.0001 = ****. (F, G) Representative immunofluorescence images (right panel)) and quantification (left panel) of CatD-positive structures in primary microglia under the indicated treatment conditions. p<.01 = **, p<.001 = ***, p<.0001 = ****. n=3, N=34-118 (uptake) and N=17-125. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as mean ± SEM and were analyzed by one-way ANOVA followed by Tukey’s test (B, E (uptake data)) or Kruskal-Wallis test followed by Dunn’s multiple-comparisons test (C, E (degradation data), F, G).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Quantitative Proteomics, Western Blot, Proteomic Assay, Derivative Assay, Activation Assay, Immunofluorescence

    (A) Reanalysis of publicly available RNA-seq data from human brain-derived microglia (GSE249315; Snijders et al., 2023) comparing LPS-stimulated and unstimulated cells. Transcriptional changes in the indicated biological processes are expressed as Cohen’s d (LPS vs. unstimulated) with 95% confidence intervals (CI). p<.01 = **, p<.001 = ***. (B) eanalysis of published proteomics data from human iPSC-derived microglia (Hellén et al., 2025) comparing LPS/IFNγ-stimulated and unstimulated cells. Changes in protein abundance are expressed as log2 fold change relative to unstimulated controls.p<.01 = **, p<.001 = ***. (C) Schematic overview (left panel) and representative immunofluorescence images (middel panel) of the engraftment of human iPSC-derived microglial precursors (iMic) into organotypic brain slice cultures. Cultures were treated with α-Syn (2 µM) and LPS (200 ng/ml) and stained for microglia (Iba1, white), α-Syn (green), CatD (red), and DAPI (blue). Fluorescence intensity profiles (left panel) illustrate the limited overlap of α-Syn and CatD signals. Scale bar, 30 µm. (D-E) Representative immunofluorescence images of post-mortem human brain tissue from neurologically healthy controls. Sections were stained for microglia (Iba1, white), phosphorylated α-Syn pSer129 (green), CatD (red), and DAPI (blue). Scale bar, 30 µm. (F-G) Representative immunofluorescence images (left panel) of post-mortem human brain tissue from patients with dementia with Lewy bodies (DLB, Braak stage 6). Sections were stained for Iba1 (white), α-Syn pSer129 (green), CatD (red), and DAPI (blue). Fluorescence intensity profiles (right panel) illustrate limited colocalization of pathological α-Syn with CatD-positive compartments. Scale bar, 30 µm. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as horizontal dot plot of module median Cohen’s d and log2 fold changes and were analyzed by paired t-test (A) and Fisher’s combined p-value (B).

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: (A) Reanalysis of publicly available RNA-seq data from human brain-derived microglia (GSE249315; Snijders et al., 2023) comparing LPS-stimulated and unstimulated cells. Transcriptional changes in the indicated biological processes are expressed as Cohen’s d (LPS vs. unstimulated) with 95% confidence intervals (CI). p<.01 = **, p<.001 = ***. (B) eanalysis of published proteomics data from human iPSC-derived microglia (Hellén et al., 2025) comparing LPS/IFNγ-stimulated and unstimulated cells. Changes in protein abundance are expressed as log2 fold change relative to unstimulated controls.p<.01 = **, p<.001 = ***. (C) Schematic overview (left panel) and representative immunofluorescence images (middel panel) of the engraftment of human iPSC-derived microglial precursors (iMic) into organotypic brain slice cultures. Cultures were treated with α-Syn (2 µM) and LPS (200 ng/ml) and stained for microglia (Iba1, white), α-Syn (green), CatD (red), and DAPI (blue). Fluorescence intensity profiles (left panel) illustrate the limited overlap of α-Syn and CatD signals. Scale bar, 30 µm. (D-E) Representative immunofluorescence images of post-mortem human brain tissue from neurologically healthy controls. Sections were stained for microglia (Iba1, white), phosphorylated α-Syn pSer129 (green), CatD (red), and DAPI (blue). Scale bar, 30 µm. (F-G) Representative immunofluorescence images (left panel) of post-mortem human brain tissue from patients with dementia with Lewy bodies (DLB, Braak stage 6). Sections were stained for Iba1 (white), α-Syn pSer129 (green), CatD (red), and DAPI (blue). Fluorescence intensity profiles (right panel) illustrate limited colocalization of pathological α-Syn with CatD-positive compartments. Scale bar, 30 µm. Schematics were created with BioRender.com and Adobe Illustrator. All graphs are presented as horizontal dot plot of module median Cohen’s d and log2 fold changes and were analyzed by paired t-test (A) and Fisher’s combined p-value (B).

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: RNA Sequencing, Derivative Assay, Proteomic Assay, Quantitative Proteomics, Immunofluorescence, Slice Preparation, Staining, Fluorescence, Tissue, IPSC

    LPS-mediated activation of TLR4 increases protein synthesis and thereby elevates intracellular proteostatic burden in microglia. Although canonical autophagic flux remains largely preserved, lysosomal adaptation becomes insufficient to meet this increased demand. As a result, aggregate-containing endolysosomal cargo shows impaired progression toward mature CatD-positive degradative compartments, leading to reduced clearance of extracellular α-Syn aggregates. Proteostatic stress induced independently of TLR4 signaling is sufficient to phenocopy the α-Syn degradation defect, whereas increasing lysosomal capacity through TFEB activation restores aggregate clearance.

    Journal: bioRxiv

    Article Title: Inflammatory proteostasis reprogramming creates a lysosomal bottleneck for microglial aggregate clearance

    doi: 10.64898/2026.11.02.763615

    Figure Lengend Snippet: LPS-mediated activation of TLR4 increases protein synthesis and thereby elevates intracellular proteostatic burden in microglia. Although canonical autophagic flux remains largely preserved, lysosomal adaptation becomes insufficient to meet this increased demand. As a result, aggregate-containing endolysosomal cargo shows impaired progression toward mature CatD-positive degradative compartments, leading to reduced clearance of extracellular α-Syn aggregates. Proteostatic stress induced independently of TLR4 signaling is sufficient to phenocopy the α-Syn degradation defect, whereas increasing lysosomal capacity through TFEB activation restores aggregate clearance.

    Article Snippet: Human WT α-Syn and Tau P301S (1N4R) was expressed in Escherichia coli BL21 (DE3) CodonPlus cells transformed with the human α-Syn (gift from Michael J Fox Foundation MJFF, Addgene plasmid #51437) or Tau P301S (1N4R) (gift from Dr. Christina Ising) expression plasmid.

    Techniques: Activation Assay